Inhibition of miR‑34a prevents endothelial cell apoptosis by directly targeting HDAC1 in the setting of atherosclerosis
Authors:
Open Access
- 9 January 2018
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 17 (3) , 4645-4650
Abstract
Despite recent medical advances, atherosclerosis is a global burden accounting for numerous mortalities and hospital admissions. MicroRNAs (miRNAs/miRs) regulate cardiovascular biology and disease, but the role of microRNA‑34a in atherosclerosis remains unclear. In the present study, it was demonstrated that miR‑34a was highly expressed in atherosclerotic lesions and oxidized low‑density lipoprotein (Ox‑LDL)‑treated human aortic endothelial cells (HAECs) (atherosclerotic cell model) using reverse transcription‑quantitative polymerase chain reaction. The expression of histone deacetylase (HDAC) 1 was reduced in atherosclerotic lesions and Ox‑LDL treated HAECs. TargetScan predicted that HDAC1 is the potential target of miR‑34a and the double‑luciferase reporter assay confirmed that HDAC1 was directly targeted by miR‑34a. Furthermore, miR‑34a inhibitor significantly enhanced the cell viability of HAECs and the cell apoptosis was suppressed. In addition, the expression of apoptotic‑related proteins was detected by western blotting. The results showed that miR‑34a inhibitor significantly upregulated B‑cell lymphoma 2, procaspase‑3, procaspase‑9 and proto‑oncogene c‑Myc protein expression, and downregulated the expression of p21. In contrast, co‑transfection of HDAC1‑small interfering RNA and miR‑34a inhibitor eliminated the effects of miR‑34a on HAECs. This indicated that miR‑34a inhibitor promoted cell viability and prevented cell apoptosis of HAECs through regulating HDAC1. In conclusion, it was demonstrated that miR‑34a promoted atherosclerotic formation by modulating the proliferation and apoptosis of HAECs, and regulating the expression of apoptosis‑related proteins by targeting HDAC1.Keywords
This publication has 22 references indexed in Scilit:
- Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34aJournal of Proteome Research, 2010
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- MicroRNA-34a regulation of endothelial senescenceBiochemical and Biophysical Research Communications, 2010
- MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1American Journal of Physiology-Endocrinology and Metabolism, 2010
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cellsBiochemical and Biophysical Research Communications, 2008
- Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheresBMC Cancer, 2008
- MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cellsOncogene, 2007
- The immune response in atherosclerosis: a double-edged swordNature Reviews Immunology, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001